<--- Back to Details
First PageDocument Content
Endocrine system / Diabetes / Dipeptidyl peptidase-4 inhibitors / Amides / Eli Lilly and Company / Anti-diabetic medication / Metformin / Vildagliptin / Exenatide / Chemistry / Organic chemistry / Anti-diabetic drugs
Date: 2014-10-09 02:50:09
Endocrine system
Diabetes
Dipeptidyl peptidase-4 inhibitors
Amides
Eli Lilly and Company
Anti-diabetic medication
Metformin
Vildagliptin
Exenatide
Chemistry
Organic chemistry
Anti-diabetic drugs

Add to Reading List

Source URL: pbs.gov.au

Download Document from Source Website

File Size: 1,84 MB

Share Document on Facebook

Similar Documents

Recall: Riomet™ (Metformin Hydrochloride Oral Solution): Microbial Contamination At PharmPix we are committed to the health and well-being of patients. It is for this reason that we inform that on November 27, 2017 the

DocID: 1vpXt - View Document

Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc

DocID: 1tj6K - View Document

Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc

DocID: 1tcHG - View Document

FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function

DocID: 1t6MV - View Document

Biguanides / Guanidines / Metformin / RTT / Renal function / Medicine / Clinical medicine / Chemistry

Schweizerische Gesellschaft für Endokrinologie und Diabetologie Société Suisse d’Endocrinologie et de Diabétologie Società Svizzera d’Endocrinologia e Diabetologia Societad Svizra d’Endocrinologia e Diabetolog

DocID: 1qXHV - View Document